Long-term efficacy of infliximab maintenance therapy for perianal Crohn&rsquo;s disease

doi:10.3748/wjg.v17.i9.1174

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4025)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

447

HTML

3064

Figures (1-6)

241

Tables (1-2)

273

Sum=4025

Mar 7, 2011 (publication date) through Jan 31, 2025

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 7, 2011; 17(9): 1174-1179
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1174

Full Size Figure Download Figure

Figure 1 Individual modified perianal Crohn’s disease activity index scores in patients before surgery and 12-15 wk after surgery with or without infliximab. The modified perianal Crohn's disease activity index (mPDAI) scores improved significantly with surgery regardless of infliximab (IFX) treatment: from 13.5 (9-16) before surgery to 9.5 (4-14) after surgery without IFX; from 11 (8-15) before surgery to 6 (1-10) with IFX (P < 0.01).

Citation: Uchino M, Ikeuchi H, Bando T, Matsuoka H, Takesue Y, Takahashi Y, Matsumoto T, Tomita N. Long-term efficacy of infliximab maintenance therapy for perianal Crohn’s disease. World J Gastroenterol 2011; 17(9): 1174-1179
URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1174.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1174